X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
cell line (6) 6
animals (4) 4
biochemistry & molecular biology (3) 3
dose-response relationship, drug (3) 3
mice (3) 3
analysis (2) 2
angiogenesis (2) 2
angiogenesis inhibitors - pharmacology (2) 2
antineoplastic agents (2) 2
apoptosis (2) 2
cell survival - drug effects (2) 2
cholesterol efflux (2) 2
cytotoxicity (2) 2
ea.hy 926 (2) 2
eahy 926 (2) 2
eahy 926 endothelial cells (2) 2
ea·hy 926 endothelial cells (2) 2
endothelial cells - drug effects (2) 2
endothelium (2) 2
endothelium - metabolism (2) 2
fibroblasts - metabolism (2) 2
hdl receptor (2) 2
human cell line eahy 926 (2) 2
index medicus (2) 2
ldl (2) 2
macrophages (2) 2
mesh : angiogenesis inhibitors (2) 2
mesh : animals (2) 2
mesh : endothelial cells (2) 2
mesh : humans (2) 2
mesh : mice (2) 2
mesh: angiogenesis inhibitors (2) 2
mesh: animals (2) 2
mesh: endothelial cells (2) 2
mesh: humans (2) 2
mesh: mice (2) 2
pathology (2) 2
pharmacology & pharmacy (2) 2
physiological aspects (2) 2
time factors (2) 2
vascular endothelium (2) 2
3-aroylindole (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.sp ] life sciences [q-bio]/pharmaceutical sciences (1) 1
[chim.orga]chemical sciences/organic chemistry (1) 1
[sdv.can] life sciences [q-bio]/cancer (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.sp]life sciences [q-bio]/pharmaceutical sciences (1) 1
a4 phosphate (1) 1
accountants (1) 1
activation (1) 1
activity in-vivo (1) 1
adenine-nucleotides (1) 1
adenosine triphosphate - pharmacology (1) 1
adenoviridae (1) 1
adenovirus (1) 1
adenoviruses (1) 1
adhesion (1) 1
administration & dosage (1) 1
adult (1) 1
adverse effects (1) 1
aged (1) 1
amphiphilic polymeric micelles (1) 1
angiogenesis inhibitors (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - chemical synthesis (1) 1
angiogenesis inhibitors - chemistry (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
angiogenesis invitro (1) 1
antiinflammatory activity (1) 1
antimitotic agents (1) 1
antimitotic antitumor agents (1) 1
antineoplastic agents - chemical synthesis (1) 1
antineoplastic agents - chemistry (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, alkylating (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, alkylating - adverse effects (1) 1
antineoplastic agents, alkylating - pharmacology (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic agents, phytogenic (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic agents, phytogenic - adverse effects (1) 1
antineoplastic agents, phytogenic - pharmacology (1) 1
antineoplastic agents, phytogenic - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumour activity (1) 1
apoptosis - drug effects (1) 1
apoptosis - physiology (1) 1
article (1) 1
atherogenesis (1) 1
atp (1) 1
basement-membrane (1) 1
behavior (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | APOPTOSIS | ANTIINFLAMMATORY ACTIVITY | ACTIVATION | CELL-CYCLE ARREST | PROLIFERATION | METASTATIC COLORECTAL-CANCER | IN-VITRO | ONCOLOGY | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | EA.hy 926 endothelial cells | INHIBITORS | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/1996, Volume 117, Issue 6, pp. 1341 - 1347
1 We have investigated the characteristics of activation of the 42kDa isoform of mitogen‐activated protein (MAP) kinase in response to various nucleotides in... 
UTP | MAP kinase | ATP | EAhy 926 endothelial cells | protein kinase C | Protein kinase C | EXTRACELLULAR ATP | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHOSPHOLIPASE-C | P2-PURINOCEPTOR | PURINOCEPTORS | INOSITOL PHOSPHATE RESPONSE | HETEROGENEITY | ADENINE-NUCLEOTIDES | PHARMACOLOGY & PHARMACY | RECEPTORS
Journal Article
Journal Article
Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, ISSN 0005-2760, 1991, Volume 1083, Issue 1, pp. 94 - 100
The properties of the HDL binding site on the permanent human cell line EAhy 926 were studied. This cell line presents with highly differentiated functions of... 
Human cell line EAhy 926 | HDL receptor | LDL | Cholesterol efflux
Journal Article
European Journal of Cell Biology, ISSN 0171-9335, 1999, Volume 78, Issue 1, pp. 44 - 55
Journal Article
Particle and Fibre Toxicology, ISSN 1743-8977, 10/2013, Volume 10, Issue 1, pp. 47 - 47
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.